Across TCGA pan-cancer cohorts, CRYGEP RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of CRYGEP’s most consistent transcriptional readouts.

The strongest signal is observed in prostate adenocarcinoma (PRAD), where CRYGEP RNA is repressed in tumor relative to normal tissue. In most cancer types CRYGEP is over-expressed in tumor, although a few such as PRAD show the opposite, repressed pattern.

PRAD are the cancer types where CRYGEP tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CRYGEP RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
PRAD	All	All	−0.087	.007	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: CRYGEP RNA expression & survival · all CRYGEP data types